Cinctive Capital Management LP

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1787258 New York, NY

Position in MDGL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,420,570

-$5,602,131 QoQ

Shares Held

4,508

-70.6% QoQ

Ownership

0.020%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#153

of 411 holders

Holding Since

Dec 2023

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Cinctive Capital Management LP holds $200,361,017 across 44 Biotechnology names. MDGL ranks #23 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	350,165	$46,477,400
2	INSM	INSMED Inc	161,996	$17,272,013
3	VRTX	Vertex Pharmaceuticals Inc / Ma	26,712	$13,268,651
4	CYTK	Cytokinetics Inc	137,838	$11,742,419
5	ROIV	Roivant Sciences Ltd.	226,140	$8,003,094
6	NTHI	Neonc Technologies Holdings, Inc.	1,607,464	$7,281,811
7	ERAS	Erasca, Inc.	391,642	$7,174,881
8	KRYS	Krystal Biotech, Inc.	16,367	$6,083,122

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,420,570	4,508	-70.6%	Shares	Sole	2026-08-14
2026-03-31	$8,022,701	15,326	+315.7%	Shares	Sole	2026-05-15
2025-12-31	$2,147,087	3,687	+2.2%	Shares	Sole	2026-02-17
2025-09-30	$1,653,927	3,606	-24.4%	Shares	Sole	2025-11-14
2025-06-30	$1,442,987	4,768	+337.0%	Shares	Sole	2025-08-14
2025-03-31	$361,371	1,091	-79.8%	Shares	Sole	2025-05-15
2024-12-31	$1,668,129	5,406	+6.5%	Shares	Sole	2025-02-12
2024-09-30	$1,076,804	5,074	+115.9%	Shares	Sole	2024-11-14
2023-12-31	$543,743	2,350	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.